PROSUS 39.190 € (-0,75 %)
INPOST 15.490 € (+0,13 %)
WORLDLINE 9.519 € (-1,07 %)
CARREFOUR 16.640 € (+0,15 %)
VEOLIA ENVIRON. 37.460 € (+1,38 %)
COMPAGNIE ODET 1 438.000 € (-1,10 %)
CSG 14.056 € (+6,23 %)
ASML HOLDING 1 555.800 € (+0,97 %)
LEGRAND 142.000 € (+1,97 %)
PHILIPS KON 23.010 € (-4,48 %)
ADP 109.100 € (-2,06 %)
AALBERTS NV 40.000 € (+1,01 %)
V LANSCHOT KEMPEN 67.300 € (+0,67 %)
CRCAM SUD R.A.CCI 217.000 € (-0,46 %)
SHELL PLC 36.865 € (+0,99 %)
TECHNIP ENERGIES 32.980 € (-0,30 %)
NN GROUP 77.480 € (+1,81 %)
RENAULT 25.840 € (-1,30 %)
CAPGEMINI 90.140 € (-1,62 %)
APERAM 46.860 € (-0,68 %)
IMCD 91.580 € (+6,24 %)
ARCELORMITTAL SA 58.720 € (+1,17 %)
ING GROEP N.V. 28.745 € (+1,14 %)
BE SEMICONDUCTOR 251.600 € (+1,86 %)
HEINEKEN 75.840 € (+0,05 %)
DSM FIRMENICH AG 84.940 € (+1,34 %)
UNILEVER 53.530 € (-0,50 %)
RELX 28.800 € (-1,44 %)
AHOLD DEL 36.120 € (+1,46 %)
KPN KON 4.345 € (+0,25 %)
WOLTERS KLUWER 61.260 € (-1,89 %)
AEGON 7.836 € (+1,79 %)
SBM OFFSHORE 32.100 € (-0,74 %)
MAGNUM 16.306 € (+0,27 %)
QUADIENT 11.960 € (-0,83 %)
SOITEC 102.750 € (+5,00 %)
PLANISWARE 20.650 € (-1,67 %)
SYNERGIE 28.100 € (-0,35 %)
AKZO NOBEL 57.340 € (-0,24 %)
AIR LIQUIDE 178.520 € (+1,01 %)
PERNOD RICARD 63.480 € (-1,15 %)
ASM INTERNATIONAL 927.600 € (+4,27 %)
SPIE 47.900 € (+0,42 %)
NANOBIOTIX 36.200 € (+3,61 %)
FORVIA 8.980 € (-2,79 %)
LVMH 482.950 € (-1,74 %)
HEIJMANS KON 96.150 € (-0,77 %)
SAINT GOBAIN 74.620 € (-0,35 %)
VALERIO TX 0.429 € (+7,25 %)
ADYEN 827.500 € (-1,92 %)
MICHELIN 34.180 € (-1,58 %)
LIGHTON 5.060 € (-4,71 %)
BENETEAU 6.080 € (-0,82 %)
KERING 244.250 € (-2,44 %)
TOTALENERGIES 71.200 € (+1,11 %)
IPSOS 35.360 € (+0,57 %)
BNP PARIBAS ACT.A 102.320 € (+1,39 %)
CAFOM 13.300 € (-3,62 %)
ESSILORLUXOTTICA 165.150 € (-2,51 %)
MAROC TELECOM 8.800 € (0,00 %) |
13/07/2026 10:00
dynion explore: new prosthetic knee joint for adolescents.
dynion explore: new prosthetic knee joint for adolescents. Monday, 13 July 2026 Ottobock expands its prosthetics portfolio. With Ottobock’s latest hydraulic prosthetic knee joint, the dynion explore, the global market leader is closing a treatment gap: Until now, active adolescents and adults with a low body weight have had few suitable options that support their active lifestyle while providing the necessary level of safety. “We want to make high-quality mobility solutions available throughout all stages of life. That is why we are specifically expanding our portfolio to serve a group of users who have previously been underserved. In doing so, we pursue our goal of providing our users with integrated fitting solutions throughout their lives,” says Arne Jörn, Chief Operating and Chief Technology Officer (COO/CTO) at Ottobock. Following its world premiere at OTWorld 2026 in Leipzig, Germany, the dynion explore will now be gradually launched, beginning in Europe, the United States and China. In Asia in particular, there is greater demand for compact solutions due to users’ generally smaller stature. This is part of an integrated treatment approach that keeps pace with life. The dynion explore enables a seamless transition from pediatric prosthetic knee joints to adult fittings: The new device makes it easier for adolescents to transition to larger microprocessor-controlled knee joints, such as the Genium X4, later in life, as they become accustomed to walking with stance phase control at an early stage. This provides high-quality treatment across all phases of life – from infancy to early adulthood. Users also benefit from a complete solution from a single source: For example, the dynion explore can be combined with the customised iconiq 3D-printed silicone liner, the Quickchange adapter and the Taleo or Evanto prosthetic feet. Developed for an active lifestyle – robust, versatile, reliable. An active, self-determined life means movement, spontaneity and versatility – especially for adolescents. People weighing up to 60 kilograms can now benefit from the compact design of the new prosthetic knee joint, which was developed specifically for highly active users. The dynion explore combines powerful rotation hydraulics with stance phase control specifically designed for users with a low body weight. This allows users to walk in a controlled yet dynamic manner, even at varying speeds and with different requirements, such as short sprints to the bus stop or outdoor activities. Thanks to stance phase control, the prosthetic knee joint flexes in a controlled manner, even under load, providing support when walking down stairs and slopes, as well as when bending down to pick up a school bag or briefcase, for example. The manual lock makes relaxed standing possible. With functions such as cycling mode that can be activated at the touch of a button and water resistance, the aluminium mechanical knee joint is designed for an active and varied lifestyle. It is resistant to fresh, salt and chlorinated water, making it ideal for the beach or swimming pool. Various colour options provide a unique, personalised look. *** Contact Nadine Winter
Ottobock, a listed global MedTech champion, combines over 100 years of tradition with outstanding innovative strength in the fields of prosthetics, neuro-orthotics and exoskeletons. Ottobock develops innovative fitting solutions for people with limited mobility and is driving the digitalization of the industry. Founded in Berlin in 1919, the company has business activities in 45 countries with nearly 9,300 employees (FTEs) worldwide and operates the largest international patient care network with around 420 patient care clinics. Ottobock is shaping the future of human bionics with a strong R&D ratio in the products and components business and over 2,600 patents and patent applications. Ottobock’s mission of improving freedom of movement, quality of life and independence is deeply rooted in the company's DNA, as is its social commitment: Ottobock has been a partner and supporter of the Paralympics since 1988.
End of Media Release Issuer: Ottobock SE & Co. KGaA Key word(s): Health 13.07.2026 CET/CEST Dissemination of a Press Release, transmitted by EQS News - a service of EQS Group.
2363624 13.07.2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||||||||||||||||
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière